RhumbLine Advisers’s Outset Medical OM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $499K | Buy |
+25,975
| New | +$499K | ﹤0.01% | 2685 |
|
|
2024
Q3 | – | Sell |
-1,495
| Closed | -$86.3K | – | 4292 |
|
|
2024
Q2 | $86.3K | Sell |
1,495
-3,113
| -68% | -$180K | ﹤0.01% | 3550 |
|
|
2024
Q1 | $153K | Buy |
4,608
+178
| +4% | +$5.93K | ﹤0.01% | 3290 |
|
|
2023
Q4 | $359K | Sell |
4,430
-49
| -1% | -$3.98K | ﹤0.01% | 2862 |
|
|
2023
Q3 | $731K | Sell |
4,479
-5
| -0.1% | -$816 | ﹤0.01% | 2380 |
|
|
2023
Q2 | $1.47M | Buy |
4,484
+147
| +3% | +$48.2K | ﹤0.01% | 2082 |
|
|
2023
Q1 | $1.2M | Buy |
4,337
+161
| +4% | +$44.4K | ﹤0.01% | 2045 |
|
|
2022
Q4 | $1.62M | Buy |
4,176
+148
| +4% | +$57.3K | ﹤0.01% | 1897 |
|
|
2022
Q3 | $963K | Buy |
4,028
+328
| +9% | +$78.4K | ﹤0.01% | 2153 |
|
|
2022
Q2 | $825K | Buy |
3,700
+424
| +13% | +$94.5K | ﹤0.01% | 2228 |
|
|
2022
Q1 | $2.23M | Buy |
3,276
+133
| +4% | +$90.6K | ﹤0.01% | 1757 |
|
|
2021
Q4 | $2.17M | Buy |
3,143
+60
| +2% | +$41.5K | ﹤0.01% | 1832 |
|
|
2021
Q3 | $2.29M | Buy |
3,083
+132
| +4% | +$97.9K | ﹤0.01% | 1831 |
|
|
2021
Q2 | $2.21M | Buy |
2,951
+2,326
| +372% | +$1.74M | ﹤0.01% | 1903 |
|
|
2021
Q1 | $510K | Sell |
625
-8
| -1% | -$6.53K | ﹤0.01% | 2485 |
|
|
2020
Q4 | $540K | Buy |
+633
| New | +$540K | ﹤0.01% | 2409 |
|